Subscription to a Drug Pricing Intelligence Database

The Patented Medicine Prices Review Board (PMPRB) of the Government of Canada is seeking a subscription to a comprehensive drug pricing intelligence database to support its international pricing and reimbursement analysis. The procurement, identified by solicitation number SN26003, is being conducted via an Advance Contract Award Notice with the intent to award the contract to GlobalData, as they are currently identified as the only supplier capable of meeting all technical requirements. The estimated total value of the contract, including options, is 392,981.00 USD. The initial performance period is scheduled from March 1, 2027, to March 31, 2028, with four additional one-year extension options. The required platform must provide global pharmaceutical price comparisons for hospital and retail sectors, featuring a flexible interface with at least 22 filtering fields and 10 years of historical data. Key technical mandates include indication-level pricing analysis, cost estimation tools, and granular profiles for at least 45 markets. Additionally, the service must offer daily headline analysis, a searchable risk-sharing database, and detailed International Reference Pricing dynamics for over 60 referrer and 80 reference markets. The contract will support up to 15 users and requires all services to be operational within 30 days of award. Other suppliers may challenge the sole-source intent by submitting a statement of capabilities by November 6, 2026.